vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and BlueLinx Holdings Inc. (BXC). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $748.9M, roughly 1.1× BlueLinx Holdings Inc.). Acadia Healthcare Company, Inc. runs the higher net margin — 0.5% vs 0.2%, a 0.3% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs 0.2%). Over the past eight quarters, BlueLinx Holdings Inc.'s revenue compounded faster (2.5% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
BlueLinx Holdings Inc. is a wholesale distributor of building and industrial products in the United States. Headquartered in Atlanta, Georgia, Shyam Reddy serves as its President and CEO.
ACHC vs BXC — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $748.9M |
| Net Profit | $4.5M | $1.7M |
| Gross Margin | — | 14.4% |
| Operating Margin | — | 1.3% |
| Net Margin | 0.5% | 0.2% |
| Revenue YoY | 7.5% | 0.2% |
| Net Profit YoY | -50.8% | -89.7% |
| EPS (diluted) | $0.05 | $0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | — | ||
| Q3 25 | $851.6M | $748.9M | ||
| Q2 25 | $869.2M | $780.1M | ||
| Q1 25 | $770.5M | $709.2M | ||
| Q4 24 | $774.2M | $710.6M | ||
| Q3 24 | $815.6M | $747.3M | ||
| Q2 24 | $796.0M | $768.4M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | — | ||
| Q3 25 | $36.2M | $1.7M | ||
| Q2 25 | $30.1M | $4.3M | ||
| Q1 25 | $8.4M | $2.8M | ||
| Q4 24 | $32.6M | — | ||
| Q3 24 | $68.1M | $16.0M | ||
| Q2 24 | $78.5M | $14.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 14.4% | ||
| Q2 25 | — | 15.3% | ||
| Q1 25 | — | 15.7% | ||
| Q4 24 | — | 15.9% | ||
| Q3 24 | — | 16.8% | ||
| Q2 24 | — | 15.9% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | — | ||
| Q3 25 | 4.7% | 1.3% | ||
| Q2 25 | 5.8% | 1.9% | ||
| Q1 25 | 1.7% | 1.5% | ||
| Q4 24 | 4.9% | 1.7% | ||
| Q3 24 | 12.1% | 3.2% | ||
| Q2 24 | 13.4% | 3.1% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | — | ||
| Q3 25 | 4.3% | 0.2% | ||
| Q2 25 | 3.5% | 0.6% | ||
| Q1 25 | 1.1% | 0.4% | ||
| Q4 24 | 4.2% | — | ||
| Q3 24 | 8.4% | 2.1% | ||
| Q2 24 | 9.9% | 1.9% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | — | ||
| Q3 25 | $0.40 | $0.20 | ||
| Q2 25 | $0.33 | $0.54 | ||
| Q1 25 | $0.09 | $0.33 | ||
| Q4 24 | $0.36 | $0.67 | ||
| Q3 24 | $0.74 | $1.87 | ||
| Q2 24 | $0.85 | $1.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $429.4M |
| Total DebtLower is stronger | $2.5B | $598.5M |
| Stockholders' EquityBook value | $2.0B | $623.0M |
| Total Assets | $5.5B | $1.6B |
| Debt / EquityLower = less leverage | 1.29× | 0.96× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | — | ||
| Q3 25 | $118.7M | $429.4M | ||
| Q2 25 | $131.4M | $386.8M | ||
| Q1 25 | $91.2M | $449.0M | ||
| Q4 24 | $76.3M | $505.6M | ||
| Q3 24 | $82.1M | $526.3M | ||
| Q2 24 | $77.2M | $491.4M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | $598.5M | ||
| Q2 25 | $2.3B | $596.4M | ||
| Q1 25 | $2.2B | $596.6M | ||
| Q4 24 | $2.0B | $575.1M | ||
| Q3 24 | $1.9B | $576.0M | ||
| Q2 24 | $1.8B | $574.6M |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | — | ||
| Q3 25 | $3.1B | $623.0M | ||
| Q2 25 | $3.1B | $621.3M | ||
| Q1 25 | $3.0B | $636.1M | ||
| Q4 24 | $3.1B | $646.4M | ||
| Q3 24 | $3.0B | $655.6M | ||
| Q2 24 | $3.0B | $652.3M |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | — | ||
| Q3 25 | $6.4B | $1.6B | ||
| Q2 25 | $6.3B | $1.6B | ||
| Q1 25 | $6.1B | $1.6B | ||
| Q4 24 | $6.0B | $1.6B | ||
| Q3 24 | $5.9B | $1.6B | ||
| Q2 24 | $5.7B | $1.6B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | 0.96× | ||
| Q2 25 | 0.74× | 0.96× | ||
| Q1 25 | 0.72× | 0.94× | ||
| Q4 24 | 0.64× | 0.89× | ||
| Q3 24 | 0.62× | 0.88× | ||
| Q2 24 | 0.62× | 0.88× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $58.6M |
| Free Cash FlowOCF − Capex | — | $52.7M |
| FCF MarginFCF / Revenue | — | 7.0% |
| Capex IntensityCapex / Revenue | — | 0.8% |
| Cash ConversionOCF / Net Profit | 13.78× | 35.42× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-25.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | — | ||
| Q3 25 | $73.2M | $58.6M | ||
| Q2 25 | $133.5M | $-26.8M | ||
| Q1 25 | $11.5M | $-33.9M | ||
| Q4 24 | $116.7M | $18.7M | ||
| Q3 24 | $163.1M | $61.8M | ||
| Q2 24 | $171.1M | $35.8M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | $52.7M | ||
| Q2 25 | $-34.2M | $-36.4M | ||
| Q1 25 | $-163.2M | $-39.8M | ||
| Q4 24 | $-86.8M | $-1.5M | ||
| Q3 24 | $-27.1M | $53.8M | ||
| Q2 24 | $16.9M | $29.3M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | 7.0% | ||
| Q2 25 | -3.9% | -4.7% | ||
| Q1 25 | -21.2% | -5.6% | ||
| Q4 24 | -11.2% | -0.2% | ||
| Q3 24 | -3.3% | 7.2% | ||
| Q2 24 | 2.1% | 3.8% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.0% | 0.8% | ||
| Q2 25 | 19.3% | 1.2% | ||
| Q1 25 | 22.7% | 0.8% | ||
| Q4 24 | 26.3% | 2.9% | ||
| Q3 24 | 23.3% | 1.1% | ||
| Q2 24 | 19.4% | 0.8% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | 35.42× | ||
| Q2 25 | 4.43× | -6.21× | ||
| Q1 25 | 1.37× | -12.09× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | 3.86× | ||
| Q2 24 | 2.18× | 2.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
BXC
| Specialty Products | $525.5M | 70% |
| Structural Products | $223.4M | 30% |
